CN201695047U - Integrated blood nucleic acid screening platform - Google Patents
Integrated blood nucleic acid screening platform Download PDFInfo
- Publication number
- CN201695047U CN201695047U CN2009200705100U CN200920070510U CN201695047U CN 201695047 U CN201695047 U CN 201695047U CN 2009200705100 U CN2009200705100 U CN 2009200705100U CN 200920070510 U CN200920070510 U CN 200920070510U CN 201695047 U CN201695047 U CN 201695047U
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- reagent
- blood
- sample
- screening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The utility model belongs to the technical field of blood screening, in particular to an integrated blood nucleic acid screening platform. A tabletop of the screening platform is planned to be divided into five function areas including a consumptive material area, a reagent area, a thermomagnetic operation area, a sample area and a waste area in sequence, wherein the thermomagnetic operation area is provided with a special thermomagnetic rotating device Agowa7200 or a thermomagnetic device consisting of a discrete component deep-well plate magnetic frame, a deep-well plate carrier, a temperature control module and an oscillation module. Screening reagents comprise a nucleic acid extraction reagent for synchronous extraction of RNA and DNA through the magnetic bead method and an RT-PCR TaqMan fluorescent probe reagent for synchronous amplification of HBV DNA, HCV RNA and HIV RNA through the one-step method. The special functions of specimen scanning, sample mixing and collecting, nucleic acid extraction, preparation of PCR reaction solution, subpackaging, sample adding and the like are controlled by programs. The screening platform is convenient to operate, and the operating process is designed, thereby greatly improving the screening efficiency and being very applicable to daily use of testing departments in blood centers and blood product enterprises at home and abroad.
Description
Technical field
The utility model belongs to the blood screening technical field, is specifically related to a kind of high-throughput, automatization, incorporate blood nucleic acid screening platform.
Background technology
The prevention and the control of the transmissible disease relevant with blood transfusion have become the focus that the whole society pays close attention to.The introduction of new technology is the important means that further improves blood safety.The nucleic acid amplification detection technique is one of the sensitiveest state-of-the-art virus detection techniques up to now, can obviously shorten " window phase ", reduces the propagation danger of haematogenous virus, is that traditional immunology detection means are important and effective additional.American-European-Japanesely under the new drug inspector instructs, blood plasma was carried out detection of nucleic acids from 1999, year December September to 2002 calendar year 2001, the screening agent of FDA approval HCV, HIV RNA; In April, 2005, FDA ratified the screening agent of HBV DNA, WNV RNA to December; In August, 2007, FDA has ratified the leading cobas TaqScreen WNV Test (Roche company) of current detection of nucleic acids art.At present, detection of nucleic acids has become American-European blood products manufacturing enterprise and has carried out the necessary means of examination raw blood plasma virus, and has promoted the use of the detection of donating blood, and market potential is huge.For example the nucleic acid blood of Chiron company sieve production marketing increases sharply to 200,000,000 dollars of 2003 from 7,000,000 dollars in 1999.
According to the official statistics numeral, because China is populous, hepatitis B, third liver and people living with AIDS reach 1.5 hundred million, 4,000 ten thousand and 800,000 respectively at present.Blood propagation is one of its important channel pathogenic and that propagate once more, therefore, adopts advanced detection technique assurance transfusion safety, blood product safety imperative.In March, 2007, SFDA works out and has issued " the blood products production of vaccine is rectified embodiment (2007) ", require the blood station that raw blood plasma is carried out detection of nucleic acids work in good time, after this China will be about to be popularized for the screening of donating blood a little later at the nucleic acid screening of raw blood plasma that is in full swing recently.Make a general survey of the practical experience of developed country and developing country, mandatory to carry out hepatitis B, third liver and hiv virus detection of nucleic acids be inexorable trend to blood products, blood station blood plasma and blood donor, and just a matter of time depends on the policy guiding of national governments.
At present, the Chiron of FDA approval and the nucleic acid blood screening reagent of Roche are closed application system, and promptly Guan Jian detecting instrument designs production voluntarily, and can only mate its special agent, can not adopt the reagent of other producer.Incompatible, to seek monopoly power technology and commercial benefits.For example Roche obtained CE approval, FDA and agreed to accept the cobas201 TaqScreen MPX Test platform of examination in March, 2007 in March, 2006, and (the COBAS AmpliPrep that Hamilton-Si Daer), automatic nucleic acid extract, the COBAS TaqMan Analyzer that detects of pcr amplification, supporting data management software AmpliLink, PDM server and special-purpose instant pack are formed automatically by the Hamiton MicrolabStar that mixes sample automatically; Roche plans will at first use at Japanese National Red Cross in higher, the bigger cobas401 platform of detection flux of release integrated degree in 2008, and its closure is also higher.Equally, year March in October, 2006-2007, (HBV/HCV/HIV unites qualitative detection to the Procleix Ultrio Assay of FDA approval Chiron, but present FDA only ratifies its HCV/HIV can be used for blood sieve purposes) the totally enclosed Procleix TIGRIS of employing system, only need the support of special software and special agent.This shows, imitated external like product must comprise the imitated of serial complex instrument, and this quasi-instrument relates to a plurality of fields such as optics, calorifics, magnetics, control automatically, mechanical manipulator, software and the liquid treatment precision is had higher requirements, and is difficult in a short time realize.Secondly, indiscriminately imitate the national conditions that American-European-Japanese practice scheme does not meet China.The one, the viral prevalence strain has region, and with American-European just different, the popular hypotype also is not quite similar as the main popular blood disease of China; The 2nd, daily test is surveyed specimen amount and is mixed the problem of sample number without the locality practice.Economic factors has determined the inspection center that is in developing country unlikely to adopt single part of blood examination of external in recent years popular to survey, and import reagent was not done large-scale examination test in China as yet, lack local proficiency research data, mix the sample number and depend on the sensitivity of examination system and examination crowd's positive rate, the virus load of " window phase " sample, day examination amount again; The 3rd, do not take into full account testing staff's working hour problem, whole process overlong time, impersonality design.As 500 samples of Procleix TIGRIS system one-time detection about 9 hours of working times of instrument only, 1000 samples then need about 14 hours; The cobas201 TaqScreen MPX Test whole process time is then longer.The two is the working hour of primary dcreening operation, in case the primary dcreening operation positive need be checked the positive or fractionation of concrete which project, the time is longer, and can not provide survey report the same day at all.Yet domestic most Blood Centers need the same day to be checked and provided report the same day.In addition, domestic bigger inspection center needs day processing 1500-3000 part sample.
In sum, this area presses for a kind of nucleic acid screening system of suitable national conditions, and can not copy international like product.
Summary of the invention
The purpose of this utility model proposes a kind of easy to operate, integrated blood nucleic acid screening platform that examination efficient is high.
The utility model people is at long-time investigation, the automatization of assessment diagnostic instrments reagent, after the incorporate process, think: in the current biological medicine industry, global well-known is semi-automatic, there is Hamilton (Hamilton) in automatic fluid handling machine people (liquor removing workstation) manufacturers, Tecan (Supreme Being agree), Beckman Coulter (Beckman Ku Erte), Perkin Elmer (Pa Jinaiermo), Eppendorf (Ai Bende), Thermo Labsystems neutral enterprises few in number such as (thermoelectricity), and Qiagen (Kai Jie company), Roche (Roche Holding Ag), Chiron (Kairong Co.,Ltd, now be the Novartis purchase, being called Novartis's diagnosis, is the instrument and the reagent of its affiliate Gen-Probe exploitation), Chemogen (Kai Mojie company) etc. is devoted to the professional enterprise of closed application.Although the instrument of neutral manufacturers only provides program-controlled and moves the liquid function and machinery moves the plate function, no functional module such as pyromagnetic, the also concrete Application Areas of indeterminate workstation, but its handiness height, expansibility is good, modularization, be easy to compatibility, be convenient to the new function of user oneself exploitation.What wherein the highest, the most suitable equally the utility model of popularity implemented in the industry is the full-automatic liquor removing workstation of Hamilton, Tecan, three brands of Beckman Coulter.The utility model is based on such liquid treatment workstation, be integrated into magnetic operational module, temperature control module, and can match elements such as oscillation module, mechanical handgrip, magnetic force frame, wherein the neutral manufacturers of some element itself can dispose, as mechanical manipulator, some element can not dispose, and as magnetic force frame, pyromagnetic integrated apparatus such as Agowa7200/2400/9600 etc., need purchase in addition and manage and match.In general, according to the necessary element of operational requirement increase of reagent, and the sequencing integration, thereby form incorporate screening platform and techniqueflow, be one of guiding theory of the present utility model.This type of workplatform that is used for blood nucleic acid screening does not still have report.
The utility model provides a kind of integrated blood nucleic acid screening platform, based on the at present existing liquid work of treatment station of moving automatically, acceptable standardized component arbitrarily in increase, modification, transformation, adjusting, the combining station, location rational in infrastructure according to planning, make each element controlled, in order, not only independent but also cooperation, automatically control by master routine, regulate arbitrarily and call, become that definite functions, target are clear, the organic combination body of distinct characteristics.In general, workstation structure of the present utility model can be divided into 5 functional zone, (but being not limited thereto) is from left to right according to this: consumptive material district (position of label 1 in the accompanying drawing), place needed consumptive material of experiment such as suction nozzle, therefore, be also referred to as the suction nozzle carrier, can load special-purpose suction nozzle, can take the 1-12 track.Reagent area (position of label 2,3,4 in the accompanying drawing), place the needed reagent of experiment, difference according to all ingredients consumption in experiment can be selected large, medium and small container and fixed loading shelf, as 4 being the comparatively large vol container in the accompanying drawing, be a reagent trough, 2 is middle volume container, it also is a reagent trough module, 3 is the smaller size smaller container, is a centrifuge tube module, and these windows all are positioned on the multi-functional carrier.Position of label 5 in the accompanying drawing 1, the hot operational zone of magnetic, place the crucial Agowa7200 of experiment, or adopt in pyromagnetic separately independent component such as the accompanying drawing 3 1., 2., 3., position 4., place deep-well plates magnetic force frame module, deep-well plates carrier, temperature control module, oscillation module respectively, these modules all are positioned on the multi-functional carrier.Sample area (8 position in the accompanying drawing) is placed specimen tube.Waste district (6 and 7 position in the accompanying drawing), the liquid that is used for placing experiment respectively is useless and solid useless.5 functional zone are suitable according to the difference of clean level
Clean area is rationally arranged to the zone of pollution, fixing on the plane that the X-axis and the Y-axis of workstation are formed, be above the planar on the Z-direction, mechanical arm or (reaching) mechanical manipulator for workstation self, having liquid-transfering device (as sample injector) on the mechanical arm can carry out pipetting to the element on the plane, can move on XY, Z axle; And mechanical manipulator can carry out move operation to the standard consumptive material in the standard component (as 96 orifice plates), can move on XY, Z axle.By master routine to the control of the sub-routine of each element with call, and itself is to intrinsic programme controlled integration of workstation such as the motion control that moves the liquid sample injector and imbibition, tapping, detecting liquid level, flow monitorings, make each element on the XY plane cooperate the mechanical movement on the Z axle to open function separately chronologically, the sample of finishing complexity scans, mixes sample and compiles and nucleic acid extraction serial special functions such as the preparation of PCR reaction solution, packing application of sample.
Core of the present utility model is to adopt the automatic liquor removing workstation that is integrated with pyromagnetic module, integrate functions such as sample scanning, the preparation that mixes sample, nucleic acid extraction, PCR reaction solution and packing, nucleic acid-templated application of sample, this stage is used the paramagnetic particle method nucleic acid extracting reagent can make the utility model implement well.Follow-up fluorescent PCR augmentation detection adopts hyperchannel fluorescent PCR instrument such as ABI 7300/7500 etc. to finish automatically.
In the utility model, the nucleic acid extraction of compiling the pond sample then requires to carry out around the concrete operations of paramagnetic particle method nucleic acid purification reagent.Key step is as follows: wash-out under the incubated at room in the sample behind the adding lysate, magnetic bead absorption nucleic acid, the washing of three steps, the heating condition.The automatic fluid work of treatment is stood then as requested, and desktop planning comprises five relatively independent functional zone.The hot main operation of most important magnetic district can have dual mode to select.A kind of is to adopt pyromagnetic incorporate assembly such as AgowaMaxiSep 7200 etc., but this assembly not only magnetic operation but also the cooling operation that can heat up; Another kind is the array configuration of the magnetic force frame (Promega etc.) that adopts 96 hole depth orifice plates, independent heating module (but make versus buy), oscillation module (being used for mixing functions), mechanical handgrip (being used to move plate).
PCR Setup then decides on breadboard actual conditions and the breadboard code of practice of gene amplification.Can finish automatically by liquor removing workstation, also can pass through function setting,, for example finish by manually transferring in other workspace with the nucleic acid-templated workstation that migrates out that extracts.Workstation is finished automatically, the preparation and the packing of PCR main reaction liquid need be set, pipettings such as the transfer of template.The artificial shrouding (PCR 96 orifice plates) that only needs, last machine augmentation detection can be finished full testing process.
Reagent described in the utility model is a kind of magnetic bead type plasma viral nucleic acid extracting reagent and TaqMan PCR nucleic acid amplification detection reagent and the quality control reagent that contains internal reference.Extract reagent and form, be instant reagent, need not to add organic volatile reagent such as ethanol or Virahol by the elutriant of washings A, the B of the magnetic bead suspension of the lysate that contains guanidinesalt, silica matrix, different concns base status, C, damping fluid matrix etc.Simple to operate: add mixing behind the lysate of (1.2-1.5) V in the sample (volume is V), simultaneously or after a while (2-10 minute) adds (0.1-2) mg magnetic bead suspension, places 20-30 minute, and middle mixing several times or the mixing of lasting low-speed oscillation.Open in magnetic field will be adsorbed with the magnetic bead side draught of nucleic acid to tube wall; Liquid-transfering needle or liquid-transfering gun begin to inhale abandons the cracking waste liquid to the useless place of liquid.Move into initial reaction cumulative volume or above washings A, the eyesight degree size mixing several seconds is opened magnetic field to several branches back, and the magnetic bead side draught is to tube wall; Remove waste liquid, add isopyknic washings B, same operation adds the elutriant of a little volume (50-200 μ l) up to removing washing liq C, and temperature control element heats it, is warming up to 55-80 ℃ and holding temperature 3-15 minute, and nucleic acid is fully eluted.While hot or be chilled to after the room temperature with nucleic acid-templated transfer to one 96 hole PCR transit plate or directly application of sample in PCR main reaction liquid.The quality control reagent that contains internal reference is mainly competitive interior mark, and interior mark is added in the effect of complete monitorings such as playing nucleic acid extraction, augmentation detection in the lysate usually, thereby implements the monitoring to each test validity.The Quality Control of also having mated every batch of test in addition: negative control and positive control (quality control product of the green safety that genetic engineering technique makes up), participate in nucleic acid extraction and augmentation detection whole process, mainly play the batch operation Quality Control of pollution and sensitivity.Can certainly use negative control and positive control in the alternative the utility model of real positive and negative sample (sensitivity sample).
TaqMan PCR nucleic acid amplification detection reagent is then by HBV reaction solution A (containing PCR damping fluid, warm start enzyme, d ATP/d CTP/d GTP/d UTP, UNG, protective material etc.), HBV reaction solution B (Mg etc.), HBV reaction liquid C (HBV primer, probe etc.); HCV/HIV reaction solution A (containing PCR damping fluid, Mg, d ATP/d CTP/d GTP/d UTP, protective material etc.); HCV/HIV reaction solution B (heat-resisting polymerase, RNA enzyme inhibitors, protective material and the optional heat-labile UNG etc. that adds that contain reversed transcriptive enzyme, warm start); HCV reaction liquid C (HCV primer, probe etc.), HIV reaction liquid C (HIV primer, probe etc.).The preparation of amplification main reaction liquid is according to A: B: C=8: 6: 1 ratio, every test packing 15 μ l, move into equal-volume (15 μ l) nucleic acid-templated after, the pad pasting sealing, can go up the fluorescent PCR instrument, press the synchronous on-line monitoring of fixed program augmentation detection, finish PCR thermal cycling post analysis data and get final product.The PCR program is room temperature-37 ℃ 1-3 minute (UNG), 50-60 ℃ 15-30 minute (reverse transcription), 95 ℃ 2-10 minute (thermally denature) is after 5 low three-step approach PCR of rigorous degree circulate in advance, TaqMan PCR:95 ℃ of 5-10 second of 40-50 standard of beginning, 60 ℃ of 30-60 seconds.
The integrated blood screening platform of the utility model design, easy to operate, in conjunction with the use of screening agent, designed the concrete operations flow process simultaneously, be very suitable for the daily use of detection department in domestic Blood Center, the blood product enterprise.
Description of drawings
Fig. 1 is one of desktop planning chart (Microlab STAR-Agowa7200) of nucleic acid extraction.
One of desktop planning chart that Fig. 2 compiles for sample (Microlab STAR-Agowa7200).
Fig. 3 be nucleic acid extraction desktop planning chart (Microlab STAR-96DW Plate) two.
Two of the desktop planning chart that Fig. 4 compiles for sample (Microlab STAR-96DW Plate).
Number in the figure:
1. suction nozzle carrier (Tips Carrier) can load special-purpose suction nozzle, can take 12 tracks;
2. the reagent trough module is positioned on the multi-functional carrier, can be 50mL * 8;
3. the centrifuge tube module is positioned on the multi-functional carrier, can be 1.5mL * 8;
4. reagent trough can take 1 track; Can be 120mL * 3;
5.
Maxisep 7200 heats, magnetic isolation integral device, can take 8 tracks;
6. waste liquid tank can take 2 tracks;
7. disposable litter bag is equipped with in the refuse district, is mainly used in to place discarded suction nozzle;
8. blood sampling test tube is placed in the test-tube stand district, and every test-tube stand can take 1 track;
9.96 hole PCR transit plate can cool off in advance, is positioned on the multi-functional carrier;
10. compiling Chi Qu, is 96 hole depth orifice plates, is positioned on the multi-functional carrier;
1.. deep-well plates magnetic force frame module is positioned on the multi-functional carrier;
2.. the deep-well plates carrier is positioned on the multi-functional carrier;
3.. temperature control module, be applicable to deep-well plates, be positioned on the multi-functional carrier;
4.. oscillation module, be applicable to deep-well plates, be positioned on the multi-functional carrier.
Embodiment
Embodiment 1 HAMILTON Microlab STAR PLUS/STAR/STARLET (full-automatic liquor removing workstation)-Agowa7200 (program control magnetic heat treatment device) scans, mixes the platform that sample compiles and automatic nucleic acid extracts as sample, and hyperchannel fluorescent PCR instrument ABI7300/7500 is as augmentation detection equipment.
With HAMILTON Microlab STARLET is example, loads the pyromagnetic integrated element of AGOWA Maxisep7200, sets up desktop planning shown in accompanying drawing 1 and accompanying drawing 2.Adopt 24 parts of mixed original mold formulas when sample compiles, specimen holder can hold 576 parts of samples (18 * 32/bar=576) and can be mixed into 24 and compile pond (576=24 * 24), repeats promptly to finish 72 3 times and compiles the pond, and the number of samples of collection reaches 1728 parts.Every part of sample sampling 30-100 μ l is to guarantee controlled sampling precision, to compile at last and get fixed volume such as 360-500 μ l sample behind the mixing of pond to nucleic acid extraction operational zone (the hot operational zone of magnetic), remaining sample stays does the archives pipe that can trace to the source, the time of this part can be controlled in 1.5 hours (the frequent degree of this blockage sensing of sighting target suction nozzle and deciding is if stopping state does not take place then finish) in 30-45 divides kind.
In case compile end, start the nucleic acid extraction program, liquid-transfering device adds sample hose and mixing with 500-600 μ l lysate (being mixed with an amount of interior mark in advance), after 5 minutes, move into 50-70 μ l magnetic bead suspension (can be mixed with the protease material), behind the mixing room temperature reaction 20-30 minute, AGOWA magnetic oscillation function is opened and is made the magnetic bead side draught in tube wall, make magnetic bead shift to the pipe end after removing liquid, pipette the washings A of 900-1000 μ l, soar with higher flow velocity and to squeeze into sample hose, magnetic bead is fully suspended down and mixing roughly in weak magnetic force control, reach the purpose of cleaning; The same magnetic oscillation function of opening, make the magnetic bead side draught in tube wall, remove washings A, add washings B and C, remove washings C at last, after guaranteeing not have residual liquid, the elutriant that adds 50-200 μ l, open temperature control and be warming up to 56-80 ℃ of (the sign temperature of software, the actual temperature of liquid in pipe is lower than this temperature) continue 5-10 minute, stop temperature control, open magnetic oscillation and make the magnetic bead side draught in tube wall, pipetting wash-out has in the 96 new hole PCR plates (transit plate) of nucleic acid-templated liquid to one, and this transit plate can be chilled to 2-8 ℃ in advance.Extract that compiling pond nucleic acid needs 3-4.5 hour approximately at full capacity, the application of sample port number of visual equipment and mechanical arm number and decide.
PCR Setup can pass through the liquid-transfering device preparing and packaging, and adds the template of extracting.The user only needs to take out 96 hole PCR plates, and machine carries out fluorescent PCR and detects and to get final product on the pad pasting.But the economy of considering can adopt the taking-up transit plate, in the compartment of regulation, uses the volley of rifle fire template to be joined in the artificial PCR main reaction liquid that preparing and packaging is good in advance machine testing on the envelope film.This step needs 1.8-2.4 hour approximately.
Embodiment 2HAMILTON Microlab STAR PLUS/STAR/STARLET (full-automatic liquor removing workstation)-deep-well plates magnetic force frame-heating module-oscillation module scans, mixes the platform that sample compiles and automatic nucleic acid extracts as sample, and hyperchannel fluorescent PCR instrument ABI7300/7500 is as (move the liquid platform and must have the mechanical manipulator that moves the plate function) of augmentation detection
Adopt 96 orifice plates to have many advantages, be the best embodiment of the utility model thought as the general consumptive material of blood screening.At first, sample is pooled to 96 hole depth orifice plates (Thermo company or Greiner company), owing to the mobility of 96 hole depth orifice plates, can persistence carry out so mix sample, and is flexible.The highest each sample disposal number reaches 2304 parts (96 * 24), thereby it is higher to detect flux.Simultaneously 96 are compiled the operator scheme in pond with 96 follow-up hole PCR mate more, do not resemble the waste that each augmentation detection the employing AGOWA7200 has 24 holes.Secondly, deep-well plates is good as the little homogeneous performance of difference between its hole of general consumptive material of standard, and every pore volume is received volume and can be arrived 2.2ml, so the sample applied sample amount can also improve.Once more, there is downward magneticaction (be magnetic still have weak downward magnetic force when being provided with) all the time in the pyromagnetic body member of AGOWA7200, blending efficiency is decreased, and adopt magnetic, heat, the isolating independent component of vibration, can indiscriminately ad. as one wishes regulate mixed effect, be easy to mixing and be not tending towards precipitation, efficiently realize the abundant absorption of magnetic bead and nucleic acid, efficiently realize the washing and the wash-out of magnetic bead.At last, independently the pyrogenicity element can avoid the aerosol that intersects to pollute, for example can adopt elutriant is heated to assigned temperature in advance after, be moved in the deep-well plates, fast may bonded nucleic acid on the magnetic bead under the wash-out.And needn't adopt the bottom to heat the pattern of magnetic bead wash-out, the viral nucleic acid of strong positive sample forms aerosol easily and pollutes.
This programme is that the desktop planning of example is shown in accompanying drawing 3, accompanying drawing 4 with HAMILTON Microlab STAR.Sample compiles as previously mentioned, and it is more mainly to be changed on the desktop open ended specimen holder, and the position of compiling the pond is positioned at the deep-well plates of multi-functional carrier.The variation of nucleic acid extraction is bigger, and details are as follows: illustrated multi-functional carrier zone vertically be provided with deep-well plates magnetic force frame module 1., the deep-well plates position 2., 3. 4. four fixed areas such as (deep-well plates) of (deep-well plates), oscillation module of heating module.
Techniqueflow:
1) deep-well plates is placed on module and 2. goes up, and liquid-transfering device moves into successively and compiles pond sample 360-500 μ l, lysate 540-750 μ l mixing 1-5 minute, adds the agent magnetic bead mixture 65-100 μ l that disinthibites again, and abundant mixing.Mechanical manipulator is grabbed this Sptting plate to oscillation module and is 4. gone up, and selects proper speed vibration 30 minutes.
2) deep-well plates is transferred to the magnetic force frame module and 1. gone up, the enough time of side draught,, inhale and remove waste liquid up to magnetic bead absorption complete (optional shallow table liquid mixing once).
3) deep-well plates is transferred to module and 2. go up, add washings A 950-1350 μ l.Mechanical manipulator is grabbed this Sptting plate to oscillation module and is 4. gone up, and selects proper speed vibration 1-2 minute.
4) deep-well plates is transferred to the magnetic force frame module and 1. gone up, the enough time of side draught, up to magnetic bead absorption fully.Discard waste liquid.
5) same repeating step 3-4 adopts washings B and C successively, and the amount that adds washing liq C is slightly more than aforementioned liquids, is used for cleaning the deep hole wooden partition along the residual aforementioned liquids of possibility; Should be noted that simultaneously that washings C will inhale as far as possible abandons totally, avoids residual liquid that downstream process is had negative influence.
6) deep-well plates being transferred to module 2. goes up, the elutriant 100-200 μ l (elutriant on heating module, be heated in advance design temperature such as 56-80 ℃) that adds preheating, transferring to oscillation module 4. went up abundant mixing 3-5 minute, shifting back module again left standstill 2-5 minute on 2., transfer to the magnetic force frame module at last and 1. go up, side draught 1-3 minute, magnetic bead was adherent fully, absorption elutes nucleic acid-templated in 96 hole PCR plates, discards the deep-well plates that contains useless magnetic bead.
Embodiment 3 application examples: adopt above-mentioned integrated screening platform that international standard substance (one-level reference material) and genotype serum dish are detected international quantitative criterion product from NIBSC (the specified nucleic acid reference material of WHO is produced the distributor):
HBV (NIBSC CODE 97/750), lyophilized powder, 5 * 105IU/vial, after redissolving with the 0.5ml purified water, concentration is: 1.0+E06IU/ml, with negative diluted plasma to 10IU/ML, 20IU/ML, 50IU/ML.
HCV (NIBSC CODE 96/798), after lyophilized powder, 5 * 104IU/vial redissolved with the 0.5ml purified water, concentration was: 1.0+E05IU/ml, with negative diluted plasma to 50IU/ML, 100IU/ML, 200IU/ML.
HIV (NIBSC CODE 97/650), lyophilized powder, 5.56log10IU/vial, after redissolving with the 0.5ml purified water, concentration is: 7.26+E05IU/ml, with negative diluted plasma to 50IU/ML, 100IU/ML, 200IU/ML.
HCV RNA Genotype Panel (NAT, genotype serum dish; NIBSC CODE 02/202), 0.5ml/ props up, and totally 6, to form by genotype 1 (02/190), 2 (02/192), 3 (02/194), 4 (02/196), 5 (02/198), 6 (02/200) respectively, concentration is 1000IU/ml.
HIV-1 RNA Genotype Reference Panel (NAT, gene hypotype serum dish; NIBSC CODE 01/466), 1.1ml/ props up, and totally 11, is made up of A, B, C, D, E (AE), F, G, H hypotypes such as (AG-GH) and O family, N family and negative control respectively.
Adopt single part of duplicate detection (multiplicity N 〉=24), the result shows that the detection sensitivity of unified platform reaches HBV20IU/ML (recall rate 〉=95%), HCV 100IU/ML (recall rate 〉=95%), HIV100IU/ML (recall rate 〉=95%), and the virus concentration of low copy still has higher recall rate, as HBV 10IU/ML (recall rate 〉=80%), HCV 50IU/ML (recall rate 〉=80%), HIV 50IU/ML (recall rate 〉=75%), diluting plasma and yin and yang attribute contrast are all normal, and interior mark is all positive.
Genotype or subgroup blood liquidation detected result are that HCV genotype 1-6 all detects, and the A of HIV-1, B, C, D, E (AE), F, G, H hypotypes such as (AG-GH) and O family, N family all detect, and the negative control result is negative; Interior mark is all positive.
Should demonstrate, the detection platform performance brilliance that the utility model is set up, the requirement of conventional nucleic acid examination has been satisfied in sensitivity, with the Procleix HCV/HIV Assay reagent of the reagent of FDA approval such as COBAS AmpliScreen HBV/HCV/HIV and Chiron (Gen-Probe) near or quite.
According to disclosure of the present utility model, those skilled in the art need not too much experiment and can successfully be implemented blood screening technology platform of the present utility model, produce a desired effect.The disclosed embodiment of the utility model is described the utility model, but does not constitute restriction of the present utility model.Those skilled in the art are with conspicuous similar surrogate or transformation; or substitute preparation described here at the relevant preparation of structure function chemically or on the biology with some; or related content of the present utility model changed; but do not exceed spirit of the present utility model, scope and thought, all fall into the claimed scope of the utility model.
Claims (1)
1. integrated blood nucleic acid screening platform, based on the existing liquid work of treatment station of moving, fusion on multi-functional carrier, configuration standard element constitute, and it is characterized in that the desktop of this platform structure is divided into following five functional zone, by from left to right being followed successively by in proper order:
(1) the required consumptive material of experiment is placed in the consumptive material district, includes suction nozzle carrier (1), for placing special-purpose suction nozzle;
(2) reagent area is placed the required screening agent of experiment, comprising a reagent trough module (2), a centrifuge tube module (3) and a reagent truss (4);
(3) pyromagnetic operational zone is placed experiment and is used Agowa7200, perhaps places the experiment hot magnetic device of being made up of discrete component, and these discrete components comprise: deep-well plates magnetic force frame module, deep-well plates carrier, temperature control module, oscillation module;
(4) sample area is placed specimen tube;
(5) useless and solid the giving up of the liquid of waste district placement experiment;
The mechanical arm and/or the mechanical manipulator that have workstation self to possess above desktop have liquid-transfering device on the mechanical arm, implement the element on the plane is carried out pipetting, and mechanical manipulator is implemented standard component is carried out move operation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009200705100U CN201695047U (en) | 2009-04-16 | 2009-04-16 | Integrated blood nucleic acid screening platform |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009200705100U CN201695047U (en) | 2009-04-16 | 2009-04-16 | Integrated blood nucleic acid screening platform |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201695047U true CN201695047U (en) | 2011-01-05 |
Family
ID=43396288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009200705100U Expired - Lifetime CN201695047U (en) | 2009-04-16 | 2009-04-16 | Integrated blood nucleic acid screening platform |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201695047U (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105296468A (en) * | 2015-10-19 | 2016-02-03 | 常熟市公安局 | Method of DNA extraction |
| CN105940105A (en) * | 2014-06-17 | 2016-09-14 | 深圳迈瑞生物医疗电子股份有限公司 | Nucleic acid extraction device and method |
| CN106754339A (en) * | 2016-12-14 | 2017-05-31 | 杭州杰毅麦特医疗器械有限公司 | Detection of nucleic acids pre-treatment automatic processing device |
| CN113219189A (en) * | 2021-05-06 | 2021-08-06 | 复旦大学附属肿瘤医院 | Sample automated processing system |
-
2009
- 2009-04-16 CN CN2009200705100U patent/CN201695047U/en not_active Expired - Lifetime
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105940105A (en) * | 2014-06-17 | 2016-09-14 | 深圳迈瑞生物医疗电子股份有限公司 | Nucleic acid extraction device and method |
| CN105296468A (en) * | 2015-10-19 | 2016-02-03 | 常熟市公安局 | Method of DNA extraction |
| CN106754339A (en) * | 2016-12-14 | 2017-05-31 | 杭州杰毅麦特医疗器械有限公司 | Detection of nucleic acids pre-treatment automatic processing device |
| CN113219189A (en) * | 2021-05-06 | 2021-08-06 | 复旦大学附属肿瘤医院 | Sample automated processing system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101538612A (en) | Integrated blood nucleic acid screening platform | |
| CN102388148B (en) | Apparatus for integrated real-time nucleic acid analysis, and method for detecting a target nucleic acid using same | |
| CN202830011U (en) | Automated nucleic acid extraction platform | |
| CN106916743A (en) | Integrated nucleic acid extraction and augmentation detection system | |
| CN201695047U (en) | Integrated blood nucleic acid screening platform | |
| CN105004596B (en) | Instrument and method for the sample preparation of integration, reaction and detection | |
| CN104215756B (en) | The mensuration system of bio-related substance | |
| CN103269787B9 (en) | Device and method for manipulating a component of an object within a tube | |
| Allain | Genomic screening for blood‐borne viruses in transfusion settings | |
| CN104762193B (en) | Nucleic acid automatically extracts micro fluidic device | |
| AU2016381806A1 (en) | Cell separation devices, systems, and methods | |
| CN107312710A (en) | DNA sequencing device and its sequence measurement based on pyrosequencing | |
| CN107893026A (en) | Detect micro-fluidic chip, detection method and the detecting system of human virus' nucleic acid | |
| CN102533525B (en) | Full-automatic hybridization appliance | |
| Chen et al. | Development of a generic microfluidic device for simultaneous detection of antibodies and nucleic acids in oral fluids | |
| CN110331092A (en) | A kind of nucleic acid complete analysis micro-fluidic chip system and its application method | |
| CN107619775B (en) | Portable nucleic acid detection platform suitable for PCR chromatography | |
| CN102253226A (en) | Integrated chip for single-reagent and multi-reagent detection and detection method | |
| CN108034565A (en) | Nucleic acid sequencing pre-treatment instrument | |
| CN101892314A (en) | Primer group and kit for detecting human platelet alloantigen gene | |
| CN110172502A (en) | A kind of detection method and detection kit of hpa gene parting | |
| CN109295183A (en) | A kind of method and system of quick detection sample of nucleic acid | |
| CN111621418A (en) | Full-automatic nucleic acid extraction appearance | |
| CN111534575B (en) | Microfluidic nucleic acid detection cartridge and kit | |
| CN112877191A (en) | Anti-pollution consumable material and method for performing CRISPR molecular diagnosis by using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20110105 |
|
| CX01 | Expiry of patent term |